📰 Adel Nada News
Adel Nada News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Adel Nada. Real-time updates on events, politics, business and more.
May 9, 2023
MILAN, ITALY / ACCESSWIRE / May 9, 2023 / Alia Therapeutics, a Trento-based start-up specializing in innovative treatments for rare genetic diseases through next-generation gene editing technology, announced
August 11, 2022
GentiBio and BMS have signed a partnership agreement for developing new engineered Treg therapies for inflammatory bowel disease patients.
August 10, 2022
/PRNewswire/ -- GentiBio, Inc., an engineered regulatory T cells (Tregs) company, announced today that it has entered into a collaboration with Bristol Myers...
June 23, 2022
/PRNewswire/ -- GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cell (Tregs) therapies for autoimmunity, autoinflammation and...
May 9, 2022
The study purported to involve nearly 1300 women – making it the largest analysis of women receiving steroids for the indication in the trial.
February 10, 2022
/PRNewswire/ -- GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology, today announced the...
February 10, 2022
/PRNewswire/ -- GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology, today announced the...
August 16, 2021
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
August 11, 2021
/PRNewswire/ -- GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology, today announced it has...